Get the Stockscreener App
13.87
0.93%
-0.13
After Hours:
13.87
Tandem Diabetes Care Inc stock is traded at $13.87, with a volume of 1.23M.
It is down -0.93% in the last 24 hours and up +13.04% over the past month.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
See More
Previous Close:
$14.00
Open:
$14.11
24h Volume:
1.23M
Relative Volume:
0.59
Market Cap:
$937.19M
Revenue:
$796.00M
Net Income/Loss:
$-136.49M
P/E Ratio:
-6.6364
EPS:
-2.09
Net Cash Flow:
$-64.24M
1W Performance:
-7.59%
1M Performance:
+13.04%
6M Performance:
-18.70%
1Y Performance:
-62.58%
1-Day Range:
$13.80
$14.35
1-Week Range:
$13.49
$15.57
52-Week Range:
$9.98
$38.94
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Name
Tandem Diabetes Care Inc
Sector
Industry
Phone
858-366-6900
Address
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
13.87 | 945.97M | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Initiated | Oppenheimer | Outperform |
| Aug-12-25 | Upgrade | Citigroup | Sell → Neutral |
| Aug-07-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-09-25 | Downgrade | Citigroup | Neutral → Sell |
| Jun-16-25 | Initiated | Truist | Hold |
| Apr-10-25 | Initiated | Mizuho | Neutral |
| Mar-05-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-04-25 | Downgrade | Citigroup | Buy → Neutral |
| Mar-03-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-28-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-06-24 | Initiated | Bernstein | Outperform |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Oct-02-24 | Initiated | RBC Capital Mkts | Outperform |
| Aug-22-24 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-08-24 | Initiated | Canaccord Genuity | Buy |
| May-30-24 | Initiated | Redburn Atlantic | Buy |
| May-22-24 | Upgrade | Citigroup | Neutral → Buy |
| Apr-29-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-25-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Mar-26-24 | Upgrade | Stifel | Hold → Buy |
| Aug-04-23 | Downgrade | Citigroup | Buy → Neutral |
| May-05-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Apr-24-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-15-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Aug-09-22 | Downgrade | Wells Fargo | Overweight → Underweight |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-20-20 | Initiated | Wells Fargo | Overweight |
| Jul-31-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jul-06-20 | Upgrade | Citigroup | Neutral → Buy |
| Jun-18-20 | Reiterated | Raymond James | Outperform |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-23-20 | Downgrade | Guggenheim | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-06-20 | Initiated | Raymond James | Outperform |
| Feb-04-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-18-19 | Initiated | Guggenheim | Buy |
| Oct-04-19 | Upgrade | UBS | Neutral → Buy |
| May-17-19 | Reiterated | BofA/Merrill | Neutral |
| May-13-19 | Initiated | SVB Leerink | Outperform |
| Mar-08-19 | Initiated | BMO Capital Markets | Outperform |
| Mar-05-19 | Reiterated | BofA/Merrill | Neutral |
| Feb-27-19 | Reiterated | Lake Street | Buy |
| Nov-21-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-26-18 | Reiterated | Dougherty & Company | Buy |
| Sep-26-18 | Reiterated | Piper Jaffray | Overweight |
View All
Tandem Diabetes Care Inc Stock (TNDM) Latest News
Using R and stats models for Tandem Diabetes Care Inc. forecasting2025 Volatility Report & Growth Focused Entry Point Reports - newser.com
Real time pattern detection on Tandem Diabetes Care Inc. stockJuly 2025 Decliners & Daily Entry Point Alerts - newser.com
Tandem Diabetes Care Inc. stock momentum explainedDividend Hike & High Accuracy Investment Signals - newser.com
Can Tandem Diabetes Care Inc. stock hit analyst price targetsJuly 2025 Levels & Precise Buy Zone Identification - newser.com
Is this a good reentry point in Tandem Diabetes Care Inc.Earnings Miss & Daily Profit Focused Stock Screening - newser.com
What indicators show strength in Tandem Diabetes Care Inc.Weekly Trend Summary & Comprehensive Market Scan Insights - newser.com
Combining machine learning predictions for Tandem Diabetes Care Inc.2025 Volatility Report & Expert Curated Trade Setups - newser.com
Candlestick signals on Tandem Diabetes Care Inc. stock todayPortfolio Update Report & Precise Buy Zone Identification - newser.com
Will Tandem Diabetes Care Inc. (TD5A) stock keep raising dividendsJuly 2025 Recap & Safe Investment Capital Preservation Plans - newser.com
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action InvestigationTNDM - Eastern Progress
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors t - GuruFocus
Tandem Diabetes, agilon health, GoodRx, Neogen, and Fortrea Stocks Trade Down, What You Need To Know - TradingView
United States Wearable Injectors Market 2025 | Industry - openPR.com
Can Tandem Diabetes Care Inc. stock deliver sustainable ROEJuly 2025 Institutional & Growth Focused Entry Reports - newser.com
Is Tandem Diabetes Care Inc. stock attractive after correction2025 Price Action Summary & Reliable Entry Point Trade Alerts - newser.com
Lobbying Update: $50,000 of TANDEM DIABETES CARE lobbying was just disclosed - Quiver Quantitative
TNDM Investor News: If You Have Suffered Losses in Tandem - GlobeNewswire
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Is Tandem Diabetes Care Inc. (TD5A) stock undervalued after correctionTrade Risk Summary & Community Trade Idea Sharing - newser.com
Should you hold or exit Tandem Diabetes Care Inc. nowJuly 2025 Short Interest & Breakout Confirmation Trade Signals - newser.com
Ongoing Securities Investigation into Tandem Diabetes Care, Inc. (TNDM)Contact Levi & Korsinsky - Newsfile
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc.TNDM - PR Newswire
Tandem Diabetes Care Stock Soars 12.2% to Intraday High of $14.85 - Markets Mojo
Tandem Diabetes Care Experiences Revision in Stock Evaluation Amid Market Fluctuations - Markets Mojo
INVESTOR ALERT: Investigation of Tandem Diabetes Care, Inc. (TNDM) Announced by Holzer & Holzer, LLC - GlobeNewswire
TNDM: Citigroup Raises Price Target to $15, Maintains Neutral Ra - GuruFocus
Shareholders Alert: Investigation Into Tandem Diabetes Care, Inc. (TNDM)Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire
Why Analysts Are Reassessing Tandem Diabetes Care as Its Growth Story Evolves - Yahoo Finance
Is Tandem Diabetes Care Inc. (TD5A) stock a contrarian opportunityPortfolio Value Summary & Daily Volume Surge Signals - newser.com
Is Tandem Diabetes Care Inc. (TD5A) stock a top pick for value investorsJuly 2025 EndofMonth & High Accuracy Swing Entry Alerts - newser.com
Fraud Investigation Opened: Levi & Korsinsky Investigates Tandem Diabetes Care, Inc. (TNDM) on Behalf of Shareholders - ACCESS Newswire
Published on: 2025-10-06 08:09:28 - earlytimes.in
Investors in Tandem Diabetes Care, Inc. (TNDM) Warned of Potential Securities FraudContact Levi & Korsinsky Today - ACCESS Newswire
Forecasting Tandem Diabetes Care Inc. price range with options dataEarnings Trend Report & Precise Swing Trade Entry Alerts - newser.com
Published on: 2025-10-05 04:46:17 - newser.com
Applying big data sentiment scoring on Tandem Diabetes Care Inc.Quarterly Market Review & Fast Gain Stock Trading Tips - newser.com
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc.TNDM - MarketScreener
Does Tandem Diabetes Care Inc. fit your quant trading modelJuly 2025 Pullbacks & Weekly Top Gainers Alerts - newser.com
Will Tandem Diabetes Care Inc. stock go up soonQuarterly Profit Review & Smart Allocation Stock Tips - newser.com
Published on: 2025-10-03 00:29:08 - newser.com
Why Tandem Diabetes Care Inc. stock remains a top recommendation - newser.com
Lost Money on Tandem Diabetes Care, Inc. (TNDM)? Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire
Press Release: Tandem Diabetes Care to Announce Third Quarter 2025 Financial Results on November 6, 2025 - 富途牛牛
Tandem Diabetes Care to Announce Third Quarter 2025 Financial Results on November 6, 2025 - Business Wire
Tandem Diabetes Care Inc Stock (TNDM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tandem Diabetes Care Inc Stock (TNDM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER |
Sep 15 '25 |
Option Exercise |
0.00 |
7,415 |
0 |
36,214 |
| Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER |
Aug 15 '25 |
Option Exercise |
0.00 |
76 |
0 |
28,839 |
| Morrison Susan | EVP & Chief Admin. Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
2,600 |
0 |
39,376 |
| Sheridan John F | PRESIDENT & CEO |
Aug 15 '25 |
Option Exercise |
0.00 |
11,453 |
0 |
115,001 |
| Carpenter Rick | Chief Technology Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
2,335 |
0 |
22,824 |
| Vosseller Leigh | EVP & CHIEF FINANCIAL OFFICER |
Aug 15 '25 |
Option Exercise |
0.00 |
2,998 |
0 |
36,258 |
| Hansen Shannon Marie | EVP & Chief Legal Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
3,065 |
0 |
19,102 |
| Gasser Elizabeth Anne | EVP, Chief Strategy Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
2,600 |
0 |
1,795 |
| Sheridan John F | PRESIDENT & CEO |
Aug 11 '25 |
Buy |
10.23 |
10,000 |
102,318 |
106,327 |
| Vosseller Leigh | EVP & CHIEF FINANCIAL OFFICER |
Aug 08 '25 |
Buy |
10.89 |
13,720 |
149,404 |
25,580 |
0.01%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):